-
ICI 118,551 Hydrochloride: Evidence and Limits
2026-09-24
ICI 118,551 hydrochloride is a β2-adrenoceptor antagonist research compound, but the cited stroke study investigated esculetin, not ICI 118,551. The study supports an esculetin–CKLF1–neutrophil mechanism in its experimental models; it does not establish a role for ICI 118,551 in stroke treatment.
-
Azilsartan Medoxomil: AT1 Blockade in Hypertension
2026-09-24
This 2017 MiniReview connects azilsartan medoxomil’s sustained AT1-receptor binding with clinical evidence of blood-pressure reduction, while noting that improved cardiovascular outcomes have not been established. Its literature-search approach and discussion of pharmacokinetics offer useful context for designing receptor and hypertension studies, but the findings should be interpreted as a narrative synthesis rather than a new trial or meta-analysis.
-
Hydrocortisone Butyrate for Reliable Cell Assays
2026-09-23
A practical guide to using Hydrocortisone butyrate (Hydrocortisone 17-butyrate), SKU N2898, in cell-based inflammation and viability workflows. It covers concentration selection, handling, interpretation of delivery-study data, and evidence-based product evaluation without assuming undocumented assay performance.
-
DIDS: Workflows for Chloride and Tumor Studies
2026-09-23
DIDS is a practical perturbation tool for connecting chloride transport, membrane signaling, vascular physiology, and cell-death biology. This guide translates its reported channel activity into controlled dose-response workflows and shows how the reference metastasis study can be tested without mistaking a broad pharmacological effect for target selectivity.
-
Regorafenib, RRM2, and Melanoma Progression
2026-09-22
A 2024 iScience study identifies RRM2 reduction as a functional component of Regorafenib activity in melanoma, linking the drug to ERK/E2F3 signaling, apoptosis, and suppression of invasive behavior. Its combined use of phenotypic assays, RNA sequencing, perturbation experiments, and in vivo validation provides a mechanistic framework for cancer biology research while leaving important translational questions unresolved.
-
How Near-Death Tumor Cells Seed Metastasis
2026-09-22
Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving an impending-death experience can enter stable prometastatic states rather than simply recover from injury. Their study defines PAMEs, links them to ER stress, reprogramming, stemness, and a cytokine storm, and identifies PAME-induced migratory cells as a paracrine mechanism that may organize metastatic tumor ecosystems.
-
Bifendate Inhibits Autophagy at Multiple Steps
2026-09-21
The reference study identifies Bifendate (DDB) as a multi-step autophagy inhibitor rather than a compound that simply changes autophagy marker abundance. Using cell-based lysosomal and lipid-accumulation models, the authors show that DDB interferes with autophagosome–lysosome fusion, lysosomal acidification, and autophagic lysosome reformation while reducing oleic acid-induced lipid droplets.
-
VE-821: Selective ATR Kinase Inhibitor Guide
2026-09-21
VE-821 is an ATP-competitive ATR kinase inhibitor for DNA damage response inhibitor studies, radiosensitization assays, and chemotherapy sensitization research. Vendor-reported biochemical potency and cellular findings support its use as a controlled in vitro tool, while the available evidence does not establish clinical or antiviral efficacy.
-
Berberrubine chloride: Research Workflows
2026-09-20
Berberrubine chloride supports mechanism-led studies spanning colorectal cancer, NSCLC chemosensitization, urate transport, and enzyme-mediated drug interaction research. This workflow-focused guide covers DMSO preparation, cell and enzyme assay design, reference-study translation, and troubleshooting for more reproducible results.
-
Cotton Gland Size and Phytoalexin Feedback
2026-09-19
The reference study identifies a GoPGF–JAVL negative feedback loop that coordinates cotton pigment-gland development, jasmonate homeostasis, and phytoalexin biosynthesis. Its findings suggest that tuning the relative activity of a positive transcriptional regulator and a VQ-domain protein may improve defense while avoiding uncontrolled metabolic activation.
-
Transcription Termination Limits WEE1-Inhibitor DNA Damage
2026-09-18
A 2026 Nucleic Acids Research study shows that transcription termination protects replicating cells from DNA damage caused by WEE1 inhibition. Genetic depletion and pharmacological perturbation identify read-through transcription and transcription–replication conflicts as actionable determinants of cancer-cell survival.
-
Ceruletide for Reliable Pancreatic Assays
2026-09-18
Learn how Ceruletide (SKU B8465) can support reproducible pancreatic function research, gastrointestinal physiology studies, and receptor-driven cell assays. This scenario-based guide covers assay compatibility, formulation, interpretation, and practical supplier selection without confusing a biological stimulus with a viability reagent.
-
Chloroquine BA1002 for Reliable Cell Assays
2026-09-17
This scenario-driven guide explains how Chloroquine (SKU BA1002) can support reproducible cell viability, proliferation, and cytotoxicity workflows. It covers lysosomal mechanism, solvent compatibility, dose selection, endpoint interpretation, and practical supplier-selection criteria.
-
3-Hydroxybutyrate (BHBA) in Ferroptosis Workflows
2026-09-17
Use 3-hydroxybutyrate (BHBA) to model ketone-driven metabolic adaptation while connecting energy status with ferroptosis and chromatin regulation. This workflow translates stroke research into practical cell-based assays with defined dosing, orthogonal readouts, and troubleshooting controls.
-
Paroxetine Mesylate in Cardiac Biomarker Research
2026-09-16
Use Paroxetine Mesylate as a controlled pharmacology probe for separating serotonergic, enzyme, kinase, and cardiac biomarker effects. This workflow connects paired EEG–ECG analysis in epileptic baboons with cell-based and colorectal cancer assays while clearly distinguishing evidence-backed findings from exploratory applications.